News Category
The latest DH Unplugged episode dissects Michael Burry's top call on AI stocks and Nvidia's plan to collateralize compute, highlighting growing market...
Regentis Biomaterials' receipt of a Japanese Notice of Allowance for its GelrinC manufacturing process strengthens its IP portfolio and supports upcom...
VERAXA Biotech's collaboration with Ardigen uses AI to optimize its BiTAC platform, potentially improving target validation and reducing development r...
VERAXA Biotech's collaboration with Ardigen aims to use AI to identify optimal dual-target combinations, potentially reviving abandoned therapies and ...
Monica Brant, a legendary fitness figure, becomes a brand ambassador for N1o1, endorsing Dr. Nathan Bryan's science-based nitric oxide products, highl...
Scientists have identified a protein on glioblastoma cells that could be targeted to make the cancer more vulnerable to existing treatments, offering ...
Nanox Imaging's subsidiary signs exclusive UK reseller agreement with Vertec Scientific for its AI-powered HealthOST bone solution, following NICE rec...
NanoViricides is set to begin a Phase II trial of its oral antiviral NV-387 for Ebola in the DRC, potentially offering a more practical treatment opti...
Helus Pharma appoints Regina Donohue as Chief People Officer and Dr. Suresh Durgam to its Scientific Advisory Board, strengthening its organizational ...
SS Innovations International's record quarterly revenue and growing installed base of its SSi Mantra robotic surgery system highlight accelerating ado...
Wolfson Group underscores the mainstreaming of gut microbiome awareness, which is reshaping consumer expectations for probiotic products and driving t...
Discover Healing's upcoming free webinar aims to educate the public on releasing trapped emotions, highlighting the growing field of energy healing an...
Freyja Healthcare's FDA clearance of VereSee™ introduces a miniature laparoscope that provides visualization during laparoscopic entry, potentially re...
REPLOID Group AG plans a 1:15 stock split to lower its share price and enhance tradability, particularly for retail investors.
Helix BioPharma's appointment of Dr. Markus Loeffler as CMO is a strategic move to accelerate its oncology pipeline, including the upcoming Phase Ib/I...
SCHOTT Pharma's parent group has updated its climate targets, validated by SBTi, with a new absolute Scope 3 emissions reduction goal, shifting focus ...
Quantum BioPharma reports significant cost reductions and FDA approval for its Phase 2 trial of Lucid-MS, a potential treatment for progressive multip...
Regentis Biomaterials is simultaneously advancing its GelrinC cartilage repair implant through US Phase III trials and European commercial rollout, ai...
Dyadic International's $2.9 million capital raise will fund working capital and general corporate purposes, supporting its development of scalable non...
Alpha Cognition's second-quarter results show accelerating ZUNVEYL demand and improved commercial execution, positioning the company for growth despit...
Streamex Corp. announced its second-quarter 2026 financial results and a business update call, introducing its new GLDC token and outlining a growth s...
Two $200,000 grants will fund research into the lung microbiome's role in cancer development and mechanisms of drug resistance, aiming to improve earl...
PX1 Research's new seven-stage testing protocol ensures 99%+ purity for research peptides, offering batch-level COA documentation and same-day shippin...
Velaris Med Spa introduces Morpheus8 RF microneedling in Burley, Idaho, providing local access to advanced skin tightening under the direct care of nu...
Knecht Orthodontics extends its orthodontic services to Anahuac, TX families, offering braces and Invisalign with advanced technology and free consult...
A comprehensive review in World Journal of Pediatric Surgery synthesizes current evidence on surgical management of necrotizing enterocolitis, emphasi...
Helix BioPharma reshuffles its board, appointing CEO Thomas Mehrling as director following Janusz Grabski's resignation, to better align governance wi...
Vycor Medical's Q2 2026 results show a revenue decline, but the company emphasizes three new peer-reviewed studies supporting the safety and efficacy ...
Onco-Innovations is progressing its precision oncology candidate ONC010 through IND-enabling activities, positioning itself in the expanding field of ...
SS Innovations International's record Q2 2026 revenue and growing installation base for its SSi Mantra surgical robot highlight the company's expandin...
Regentis Biomaterials' new Japanese patent for its GelrinC manufacturing process and liquid formulation bolsters its IP portfolio in a key market, sup...
Regentis Biomaterials advances its GelrinC hydrogel implant with European approval for a solvent-free manufacturing process, targeting a multi-billion...
Gaxos.ai's warrant exercise agreement is expected to raise $3.6 million, providing crucial capital for working capital and general corporate purposes.
Researchers at the University of Manchester discovered that a small group of immune cells, often overlooked, are crucial for mobilizing and sustaining...
Quantum BioPharma reported reduced Q2 expenses and FDA approval to proceed with a Phase 2 trial for Lucid-MS, a potential treatment for progressive mu...
Regentis Biomaterials is simultaneously advancing its cartilage repair product GelrinC through US clinical trials and European commercialization, with...
HeartBeam's second-quarter results show progress in its heart attack detection studies and commercial launch, with cash runway extended into 2027.
Lantern Pharma's Q2 2026 results highlight progress in its AI-driven oncology pipeline, including promising LP-300 trial data and the establishment of...
Redwood AI's acquisition of Quantum.IQ Technologies marks a strategic expansion into quantum cybersecurity, positioning the company to address emergin...
Helus Pharma reports enrollment completion in its pivotal Phase 3 APPROACH trial for HLP003 in major depressive disorder, with topline data expected i...
DM Clinical Research marks its 20th anniversary, highlighting its growth into a leading clinical research network and its ongoing commitment to broade...
Burcon Nutrascience's Q1 2027 results show significant revenue growth and customer expansion, but the company must execute on capacity and financing t...
NeOnc Technologies reported positive Phase 2a data for NEO100 in recurrent brain cancer, with significant survival benefits and regulatory clarity, po...
PX1 Research expands its peptide catalog with domestically manufactured retatrutide and tirzepatide, each batch verified for 99%+ purity via HPLC, sup...
Quantum BioPharma's Lucid-MS focuses on inhibiting myelin degradation to address progression independent of relapse activity, a key driver of long-ter...
Carolina Age Management Institute has rebranded as Cami Aesthetics, signaling a commitment to consistent, integrity-driven care across its North Carol...
GeoVax announces its preparedness to contribute its MVA-based hemorrhagic fever vaccine expertise and candidates to the global response against the ra...
Global drugmakers are investing approximately $500 billion in the US to avoid planned tariffs on drug imports, with major companies like Amgen, AbbVie...
